Elizabeth “Lyz” Kneeland joins the Chilmark team with a background in telemedicine, sleep medicine, data, and more. We’re excited to have her aboard!
The ATA conference returned this month, amidst a tumultuous time for telehealth. How did it stack up in the hotly contested health conference space?
The next generation of healthcare tools are here now. How can providers better engage with consumers to help them participate in their patient journey?
Chilmark Senior Analyst Alex Lennox-Miller sat down with Dr. Danny Sands, from the Society of Participatory Medicine, to talk about how providers can better engage their patients in their journey through the healthcare system.
COVID has accelerated the adoption of a host of technologies in healthcare. What can the C-suite do to ensure that change and growth come smoothly?
While these changes are being forced due to an episodic event, COVID-19, there is a strong likelihood that the changes will become systemic, forever changing how care is delivered.
On Friday, October 26, the Centers for Medicare and Medicaid Services (CMS) announced several rule changes that affect how telehealth services will be covered under Medicare Advantage (MA) and the Medicare prescription drug program (Part D). These changes are in direct response to the Bipartisan Budget Act of 2018, which eliminated historical restrictions on telehealth reimbursement, and are intended to “improve quality of care and provide more plan choices for MA and Part D enrollees.”